Nika Biotechnology Stock Price Prediction

NIKA Stock  USD 0.28  0.00  0.00%   
At this time, the relative strength index (RSI) of Nika BioTechnology's share price is approaching 42. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Nika BioTechnology, making its price go up or down.

Momentum 42

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of Nika BioTechnology's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Nika BioTechnology, which may create opportunities for some arbitrage if properly timed.
Using Nika BioTechnology hype-based prediction, you can estimate the value of Nika BioTechnology from the perspective of Nika BioTechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Nika BioTechnology to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Nika because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Nika BioTechnology after-hype prediction price

    
  USD 0.28  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Nika BioTechnology Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.010.278.58
Details
Naive
Forecast
LowNextHigh
0.010.328.63
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.200.300.41
Details

Nika BioTechnology After-Hype Price Prediction Density Analysis

As far as predicting the price of Nika BioTechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nika BioTechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Nika BioTechnology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Nika BioTechnology Estimiated After-Hype Price Volatility

In the context of predicting Nika BioTechnology's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nika BioTechnology's historical news coverage. Nika BioTechnology's after-hype downside and upside margins for the prediction period are 0.01 and 8.59, respectively. We have considered Nika BioTechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.28
0.28
After-hype Price
8.59
Upside
Nika BioTechnology is out of control at this time. Analysis and calculation of next after-hype price of Nika BioTechnology is based on 3 months time horizon.

Nika BioTechnology Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Nika BioTechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nika BioTechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nika BioTechnology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.26 
8.31
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.28
0.28
0.00 
0.00  
Notes

Nika BioTechnology Hype Timeline

Nika BioTechnology is now traded for 0.28. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Nika is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.26%. %. The volatility of related hype on Nika BioTechnology is about 0.0%, with the expected price after the next announcement by competition of 0.28. The company had not issued any dividends in recent years. Nika BioTechnology had 1:15 split on the 21st of July 2021. Given the investment horizon of 90 days the next forecasted press release will be uncertain.
Check out Nika BioTechnology Basic Forecasting Models to cross-verify your projections.

Nika BioTechnology Related Hype Analysis

Having access to credible news sources related to Nika BioTechnology's direct competition is more important than ever and may enhance your ability to predict Nika BioTechnology's future price movements. Getting to know how Nika BioTechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nika BioTechnology may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BHHKFBenchmark Botanics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ABTIAlterola Biotech 0.00 0 per month 0.00  0.12  0.00  0.00  0.00 
CPHRFCipher Pharmaceuticals 0.00 0 per month 0.00 (0.06) 3.95 (2.63) 14.31 
EDTXFSpectral Med 0.00 0 per month 0.00 (0.02) 5.88 (6.86) 37.45 
CMVLFCellectis SA 0.00 0 per month 0.00  0.12  0.00  0.00  74.56 
BHCCFBenchmark Holdings plc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
IDGXFIntegrated Diagnostics Holdings 0.00 0 per month 0.00  0.11  11.11 (3.08) 30.53 
COGZFCogstate Limited 0.00 0 per month 2.99  0.08  11.89 (6.54) 34.92 
FGHQFFrontage Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PSIQProfile Solutions 0.00 6 per month 0.00  0.00  0.00  0.00  0.00 

Nika BioTechnology Additional Predictive Modules

Most predictive techniques to examine Nika price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nika using various technical indicators. When you analyze Nika charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Nika BioTechnology Predictive Indicators

The successful prediction of Nika BioTechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nika BioTechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nika BioTechnology based on analysis of Nika BioTechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nika BioTechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nika BioTechnology's related companies.

Story Coverage note for Nika BioTechnology

The number of cover stories for Nika BioTechnology depends on current market conditions and Nika BioTechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nika BioTechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nika BioTechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Complementary Tools for Nika Pink Sheet analysis

When running Nika BioTechnology's price analysis, check to measure Nika BioTechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nika BioTechnology is operating at the current time. Most of Nika BioTechnology's value examination focuses on studying past and present price action to predict the probability of Nika BioTechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nika BioTechnology's price. Additionally, you may evaluate how the addition of Nika BioTechnology to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios